• Zydus Gets USFDA Approval for Methenamine Hippurate Tablets USP, 1g

    Ahmedabad, India, 12 March, 2025 Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex® Tablets, 1 gram). Methenamine Hippurate tablets are indicated for prophylactic or suppressive treatment of frequently

    Continue Reading

Search

About

At NexGen Consulting, we specialize in strategic media planning that helps brands secure the best possible coverage—across both digital and print media. With a focus on visibility, credibility, and audience engagement, we ensure your message reaches the right people, at the right time, through the right platforms.

As a results-driven media consulting agency, we work closely with businesses, startups, and professionals to build strong media presence and brand authority. Whether you need features in top publications, digital news coverage, influencer reach, or targeted content placement, our team ensures maximum impact with smart, data-backed planning.

Archive

Gallery